Showing results (221-230 of 467) with videos related to
Sort By:
Pageof 47
Hepatology (Baltimore, Md.)|April 26, 2012
von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosisMonika Ferlitsch, Thomas Reiberger, Matthias Hoke, et al.Plos One|June 4, 2021
Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapyCaroline Schmidbauer, Michael Schwarz, Angelika Schütz, et al.Wiener Klinische Wochenschrift|December 22, 2020
Direct patient-physician communication via a hepatitis C hotline facilitates treatment initiation in patients with poor adherenceLisa Steininger, David Chromy, David Bauer, et al.Wiener Klinische Wochenschrift|December 15, 2015
Treatment intensification with boceprevir in HIV-positive patients with acute HCV-genotype 1 infection at high risk for treatment failureMattias Mandorfer, Sebastian Steiner, Philipp Schwabl, et al.Hepatology (Baltimore, Md.)|November 28, 2019
The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver TransplantationGeorg P Györi, David Pereyra, Benedikt Rumpf, et al.Cancers|October 17, 2020
Vascular Complications in Patients with Hepatocellular Carcinoma Treated with SorafenibKatharina Pomej, Bernhard Scheiner, Dabin Park, et al.Gut|December 20, 2012
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranololThomas Reiberger, Gregor Ulbrich, Arnulf Ferlitsch, et al.Journal of Hepatology|December 25, 2012
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosisThomas Reiberger, Arnulf Ferlitsch, Berit A Payer, et al.The Journal of Clinical Endocrinology and Metabolism|May 13, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of MortalityGeorg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.Digestive Diseases and Sciences|December 26, 2019
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on MortalityLukas W Unger, Bernadette Forstner, Moritz Muckenhuber, et al.Pageof 47